articleThe LancetFeb 1, 2026Closed access

Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial

YXYunyun XiongFAFana AlemsegedZCZhixin CaoLHLee H SchwammSZSi Zhang

Beijing Tian Tan Hospital · The Royal Melbourne Hospital · +19 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

4
total citations
FWCI
76.11
Percentile
99%
References
29
Too recent for citation history.

Authors

128

Topics & keywords

Topics
Keywords
  • Tenecteplase
  • Medical treatment
  • Beijing
  • Basilar artery
  • China
  • Clinical trial
No related works found for this paper.

Funding